Cash, cash equivalents, and marketable securities of $360.1 million at Q3 2024 - CARLSBAD, Calif., Nov. 7, 2024 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical ...
Kidney disease is a global health concern, but conventional tests that check creatinine levels often overlook early signs of damage. To solve this, researchers developed an innovative biosensor that ...